Skip to main content
All lobbying filings

DRUG POLICY ALLIANCE

Lobbying for DRUG POLICY ALLIANCE

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · New York · $18,639.00 expenses · posted Jul 17, 2026

Official filing document

 Bills named in this filing 8
 Lobbying activity 3
Law Enforcement/Crime/Criminal Justice

We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to support and co-sponsor the Cannabis Administration and Opportunity Act in the Senate. We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).

Civil Rights/Civil Liberties

We urged Congress to support the RESTORE Act (H.R. 5223), a bill that would end the SNAP drug felony ban. We urged Congress to repeal the Thurmond Amendment to end housing discrimination via a bill called the Fair Future Act (H.R. 7765).

Health Issues

We urged Congress to fully fund health programs that support people struggling with addiction in Congressional spending bills (LHHS FY27 appropriations bills). We opposed the inclusion of a rider to ban overdose prevention centers in Congressional spending bills.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem